Benshang Li
Shanghai Jiao Tong University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Benshang Li.
Nature Medicine | 2015
Benshang Li; Hui Li; Yun Bai; Renate Kirschner-Schwabe; Jun Yang; Yao Chen; Gang Lu; Gannie Tzoneva; Xiaotu Ma; Tongmin Wu; Wenjing Li; Haisong Lu; Lixia Ding; Huanhuan Liang; Xiaohang Huang; Minjun Yang; Lei Jin; Hui Kang; Shuting Chen; Alicia Du; Shuhong Shen; Jianping Ding; Hongzhuan Chen; Jing Chen; Arend von Stackelberg; Long-Jun Gu; Jinghui Zhang; Adolfo A. Ferrando; Jing-Yan Tang; Shengyue Wang
Relapse is the leading cause of mortality in children with acute lymphoblastic leukemia (ALL). Among chemotherapeutics, thiopurines are key drugs in ALL combination therapy. Using whole-exome sequencing, we identified relapse-specific mutations in the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS1), which encodes a rate-limiting purine biosynthesis enzyme, in 24/358 (6.7%) relapsed childhood B cell ALL (B-ALL) cases. All individuals who harbored PRPS1 mutations relapsed early during treatment, and mutated ALL clones expanded exponentially before clinical relapse. Our functional analyses of PRPS1 mutants uncovered a new chemotherapy-resistance mechanism involving reduced feedback inhibition of de novo purine biosynthesis and competitive inhibition of thiopurine activation. Notably, the de novo purine synthesis inhibitor lometrexol effectively abrogated PRPS1 mutant–driven drug resistance. These results highlight the importance of constitutive activation of the de novo purine synthesis pathway in thiopurine resistance, and they offer therapeutic strategies for the treatment of relapsed and thiopurine-resistant ALL.
EBioMedicine | 2016
Yuan-Fang Liu; Bai-Yan Wang; Wei-Na Zhang; Jin-Yan Huang; Benshang Li; Ming Zhang; Lu Jiang; Jian-Feng Li; Wang Mq; Yu-Jun Dai; Z. Zhang; Qiang Wang; Jie Kong; Bing Chen; Yong-Mei Zhu; Xiang-Qin Weng; Zhi-Xiang Shen; Junmin Li; Jin Wang; Xiao-Jing Yan; Yan Li; Yingmin Liang; Li Liu; Xie-Qun Chen; Wang-Gang Zhang; Jin-Song Yan; Jianda Hu; Shuhong Shen; Jing Chen; Long-Jun Gu
Genomic landscapes of 92 adult and 111 pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL) were investigated using next-generation sequencing and copy number alteration analysis. Recurrent gene mutations and fusions were tested in an additional 87 adult and 93 pediatric patients. Among the 29 newly identified in-frame gene fusions, those involving MEF2D and ZNF384 were clinically relevant and were demonstrated to perturb B-cell differentiation, with EP300-ZNF384 inducing leukemia in mice. Eight gene expression subgroups associated with characteristic genetic abnormalities were identified, including leukemia with MEF2D and ZNF384 fusions in two distinct clusters. In subgroup G4 which was characterized by ERG deletion, DUX4-IGH fusion was detected in most cases. This comprehensive dataset allowed us to compare the features of molecular pathogenesis between adult and pediatric B-ALL and to identify signatures possibly related to the inferior outcome of adults to that of children. We found that, besides the known discrepancies in frequencies of prognostic markers, adult patients had more cooperative mutations and greater enrichment for alterations of epigenetic modifiers and genes linked to B-cell development, suggesting difference in the target cells of transformation between adult and pediatric patients and may explain in part the disparity in their responses to treatment.
Leukemia | 2006
Benshang Li; Long-Jun Gu; C Y Luo; W S Li; L M Jiang; Shuhong Shen; H Jiang; B Zhang; J Chen; H L Xue; Jing-Yan Tang
The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L -asparaginase
Leukemia | 2017
Zhaodong Li; Brian J. Abraham; Alla Berezovskaya; Nadine Farah; Yu Liu; Theresa E. León; Adele K. Fielding; Shi Hao Tan; Takaomi Sanda; Abraham S. Weintraub; Benshang Li; Shuhong Shen; Jinghui Zhang; Marc R. Mansour; Richard A. Young; A T Look
Oncogenic driver mutations are those that provide a proliferative or survival advantage to neoplastic cells, resulting in clonal selection. Although most cancer-causing mutations have been detected in the protein-coding regions of the cancer genome; driver mutations have recently also been discovered within noncoding genomic sequences. Thus, a current challenge is to gain precise understanding of how these unique genomic elements function in cancer pathogenesis, while clarifying mechanisms of gene regulation and identifying new targets for therapeutic intervention. Here we report a C-to-T single nucleotide transition that occurs as a somatic mutation in noncoding sequences 4 kb upstream of the transcriptional start site of the LMO1 oncogene in primary samples from patients with T-cell acute lymphoblastic leukaemia. This single nucleotide alteration conforms to an APOBEC-like cytidine deaminase mutational signature, and generates a new binding site for the MYB transcription factor, leading to the formation of an aberrant transcriptional enhancer complex that drives high levels of expression of the LMO1 oncogene. Since APOBEC-signature mutations are common in a broad spectrum of human cancers, we suggest that noncoding nucleotide transitions such as the one described here may activate potent oncogenic enhancers not only in T-lymphoid cells but in other cell lineages as well.
International Journal of Oral and Maxillofacial Surgery | 2015
H. Yu; Benshang Li; L.L. Zhang; Steve Guofang Shen; X. Wang
Mandibular condylar osteochondroma (OC) results in asymmetric prognathism with facial morphology and functional disturbances. The aim of this study was to explore the feasibility of computer-assisted surgical planning combined with intraoperative navigation in the treatment of condylar OC. Five patients with mandibular condylar OC were enrolled in this study. Surgical planning and simulation was performed based on a computed tomography reconstruction model using SurgiCase software. Under the guidance of navigation, a condylar OC resection and conservative condylectomy was carried out via intraoral approach. Simultaneous orthognathic surgery was used to correct the facial asymmetry and malocclusion. All patients healed uneventfully. No facial nerve injury or salivary fistula occurred. Facial symmetry and morphology were greatly improved and stable occlusion was obtained in all cases. Good matching between preoperative planning and postoperative results was achieved. Patients showed no signs of recurrence or temporomandibular joint ankylosis during follow-up of 12-30 months. Computer-assisted surgical planning and intraoperative navigation is a valuable option in the treatment of mandibular condylar OC.
Proceedings of the National Academy of Sciences of the United States of America | 2018
Bing Chen; Lu Jiang; Meng-Ling Zhong; Jian-Feng Li; Benshang Li; Lijun Peng; Yuting Dai; Bowen Cui; Tian-Qi Yan; Wei-Na Zhang; Xiang-Qin Weng; Yin-Yin Xie; Jing Lu; Rui-Bao Ren; Suning Chen; Jianda Hu; Depei Wu; Zhu Chen; Jing-Yan Tang; Jin-Yan Huang; Jian-Qing Mi; Sai-Juan Chen
Significance To get more insights into the disease mechanism of T-cell acute lymphoblastic leukemia (T-ALL), particularly in an adult group, we addressed the genomic landscape in 130 patients, including 61 cases of adult T-ALL. A number of new genetic aberrations were identified using integrated transcriptome and genomic analysis. Distinct T-ALL subgroups were defined according to the interplay among different genetic abnormalities and gene transcription patterns. Characterization of genomic features of T-ALL is valuable not only for a better understanding of leukemogenesis, but also for patient stratification and tailored therapy. T-cell acute lymphoblastic leukemia (T-ALL) is a clonal malignancy of immature T cells. Recently, the next-generation sequencing approach has allowed systematic identification of molecular features in pediatric T-ALL. Here, by performing RNA-sequencing and other genomewide analysis, we investigated the genomic landscape in 61 adult and 69 pediatric T-ALL cases. Thirty-six distinct gene fusion transcripts were identified, with SET-NUP214 being highly related to adult cases. Among 18 previously unknown fusions, ZBTB16-ABL1, TRA-SALL2, and involvement of NKX2-1 were recurrent events. ZBTB16-ABL1 functioned as a leukemogenic driver and responded to the effect of tyrosine kinase inhibitors. Among 48 genes with mutation rates >3%, 6 were newly found in T-ALL. An aberrantly overexpressed short mRNA transcript of the SLC17A9 gene was revealed in most cases with overexpressed TAL1, which predicted a poor prognosis in the adult group. Up-regulation of HOXA, MEF2C, and LYL1 was often present in adult cases, while TAL1 overexpression was detected mainly in the pediatric group. Although most gene fusions were mutually exclusive, they coexisted with gene mutations. These genetic abnormalities were correlated with deregulated gene expression markers in three subgroups. This study may further enrich the current knowledge of T-ALL molecular pathogenesis.
International Journal of Oral and Maxillofacial Surgery | 2016
Benshang Li; Steve Guofang Shen; H. Yu; Jianfu Li; James J. Xia; X. Wang
The purpose of this study was to develop and validate a new chin template system for a two-piece narrowing genioplasty. Nine patients with wide chin deformities were enrolled. Surgeries were planned with the computer-aided surgical simulation (CASS) planning method. Surgical splints and chin templates were designed in a computer and fabricated using a three-dimensional printing technique. The chin template system included a cutting guide and a repositioning guide for a two-piece narrowing genioplasty. These guides were also designed to avoid the mental foramen area and inferior alveolar nerve loops during the osteotomy, for nerve protection. After surgery, the outcome evaluation was completed by first superimposing the postoperative computed tomography model onto the planned model, and then measuring the differences between the planned and actual outcomes. All surgeries were completed successfully using the chin template system. No inferior alveolar nerve damage was seen in this study. With the use of the chin templates, the largest linear root mean square deviation (RMSD) between the planned and the postoperative chin segments was 0.7mm and the largest angular RMSD was 4.5°. The results showed that the chin template system provides a reliable method of transfer for two-piece osseous narrowing genioplasty planning.
Journal of Huazhong University of Science and Technology-medical Sciences | 2011
Yingyi He; Benshang Li; Changying Luo; Shuhong Shen; Jing Chen; Huiliang Xue; Jing-Yan Tang; Long-Jun Gu
This study investigated the intracellular localization of asparagine synthetase (ASNS) in the relation with chemoresistance in leukemia. pIRES-GFP-ASNS-Flag/Neo expression vector was transiently tansfected into SK-N-MC cells and 297T cells respectively. Immunofluorescence and Western blot analysis were performed for cellular localization of ASNS respectively. U937 cells were treated with L-asparaginase for 48 h and examined for endogenous ASNS expression on plasma membrane by immunofluorescence staining. Immunofluorescence staining showed that the transiently expressed ASNS was partly localized on transfected-SK-N-MC cell surface. Moreover, Western blotting exhibited that ASNS expressed both in cytosol and on plasma membrane of transfected-293T cells. Immunofluorescence staining with anti-ASNS-specific monoclonal antibody revealed that endogenous ASNS was localized on the plasma membrane of U937 cells, except for its distribution in the cytosol. In addition, ASNS exhibited a higher expression on plasma membrane after treatment with L-asparaginase as compared with the untreated cells. It was concluded that the subcellular translocation of ASNS may play an important role in L-asparaginase resistance in leukemia cells.SummaryThis study investigated the intracellular localization of asparagine synthetase (ASNS) in the relation with chemoresistance in leukemia. pIRES-GFP-ASNS-Flag/Neo expression vector was transiently tansfected into SK-N-MC cells and 297T cells respectively. Immunofluorescence and Western blot analysis were performed for cellular localization of ASNS respectively. U937 cells were treated with L-asparaginase for 48 h and examined for endogenous ASNS expression on plasma membrane by immunofluorescence staining. Immunofluorescence staining showed that the transiently expressed ASNS was partly localized on transfected-SK-N-MC cell surface. Moreover, Western blotting exhibited that ASNS expressed both in cytosol and on plasma membrane of transfected-293T cells. Immunofluorescence staining with anti-ASNS-specific monoclonal antibody revealed that endogenous ASNS was localized on the plasma membrane of U937 cells, except for its distribution in the cytosol. In addition, ASNS exhibited a higher expression on plasma membrane after treatment with L-asparaginase as compared with the untreated cells. It was concluded that the subcellular translocation of ASNS may play an important role in L-asparaginase resistance in leukemia cells.
Nature Communications | 2017
Brian J. Abraham; Abraham S. Weintraub; Nicholas Kwiatkowski; Charles H. Li; Zhaodong Li; Nina Weichert-Leahey; Sunniyat Rahman; Yu Liu; Julia Etchin; Benshang Li; Shuhong Shen; Tong Ihn Lee; Jinghui Zhang; A. Thomas Look; Marc R. Mansour; Richard A. Young
This corrects the article DOI: 10.1038/ncomms14385.
Pediatric Blood & Cancer | 2018
Liu Yang; Lixia Ding; Jianwei Liang; Jing Chen; Yanjing Tang; Huiliang Xue; Long-Jun Gu; Shuhong Shen; Benshang Li
Mixed‐lineage leukemia (MLL) with multifarious partner genes leads to aggressive leukemia with dismal outcomes.